Electroacupuncture and Exercise for Chemotherapy-Induced Peripheral Neuropathy (CIPN)
NCT: NCT07700901 · RECRUITING
Brief Summary
Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer treatment that causes numbness, pain, and balance issues in a patient's hands and feet. This study focuses on finding a non-drug approach to help cancer survivors manage these uncomfortable symptoms. The main purpose of this research is to evaluate whether combining Electroacupuncture(EA) with a exercise training program works better than using electroacupuncture alone. Electroacupuncture uses gentle electrical pulses through acupuncture needles to stimulate nerves, while the exercise program aims to improve a patient's balance, physical strength, and movement safety. Participants will be randomly assigned to receive either the combination therapy or electroacupuncture alone. The study involves scheduled hospital visits along with home-based practice guided by instructional videos. The researchers aim to evaluate the efficacy of combined EA and exercise training program on neurological symptoms and quality of life in CIPN patients across different CTCAE grades.
Frequently Asked Questions
What is Electroacupuncture and Exercise for Chemotherapy-Induced Peripheral Neuropathy (CIPN)?
Electroacupuncture and Exercise for Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a clinical trial registered under NCT07700901. Current status: RECRUITING.
What is the status of NCT07700901?
The current status of NCT07700901 (Electroacupuncture and Exercise for Chemotherapy-Induced Peripheral Neuropathy (CIPN)) is: RECRUITING.
When did Electroacupuncture and Exercise for Chemotherapy-Induced Peripheral Neuropathy (CIPN) start?
Electroacupuncture and Exercise for Chemotherapy-Induced Peripheral Neuropathy (CIPN) started on 2026-07-23.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.